Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|May 29, 2007
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)Annick Chauty, Marie-Françoise Ardant, Ambroise Adeye, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of TuberculosisRokeya Tasneen, Deborah S Mortensen, Paul J Converse, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailabilityRadojka M Savic, Yanhui Lu, Erin Bliven-Sizemore, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosisDalin Rifat, Si-Yang Li, Thomas Ioerger, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of TuberculosisJian Xu, Rokeya Tasneen, Charles A Peloquin, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2019
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of TuberculosisVikram Saini, Nicole C Ammerman, Yong Seok Chang, et al.
ACS Infectious Diseases|March 9, 2017
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1Pooja Gopal, Rokeya Tasneen, Michelle Yee, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling StudyKendra K Radtke, Jacqueline P Ernest, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.
Pageof 8